Benzinga
Benzinga
Benzinga
jueves, septiembre 17

Healthpeak Properties Inc

DOCNYSE
Trade with Public
Trade with Public
$20.35
0.190.94%
al cierre: Sep 16, 5:00 PM EST
$20.32
-0.03-0.15%
After hour: 7:06 PM EST
Dividendo: La fecha límite del dividendo era hace 2 días
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

Healthpeak Properties Analyst Price Targets

Wall Street analyst price targets and consensus rating for Healthpeak Properties (DOC).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

8Buy
11Hold
Consensus RatingOutperform# Analysts19Avg. Consensus PT$21Upside to Avg. PT+4.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Sep 15, 2026JefferiesJoe DicksteinAssumesHold$22→$21
Aug 31, 2026BarclaysRichard HightowerPT RaiseEqual-Weight$23→$24
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Jefferies Assumes Healthpeak Properties at Hold, Lowers Price Target of $21

Jefferies analyst Joe Dickstein assumes Healthpeak Properties (NYSE:DOC) with a Hold rating and lowers Price Target of $21.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $24

Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $23 to $24.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Avi Kapoor

PRO
Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved